As pharmacists, our role goes beyond dispensingwe translate mechanisms into better patient outcomes
Enzymatic degradation in the digestive tract substantially reduces bioavailability, often to the point where clinical benefits become questionable
As a black, woman, and veteran-owned company, Defy is proud to partner with like-minded brands that are committed to empowering every single person to defy the odds and achieve their version of success, said CEO Megan Bushell
Injectable BPC-157 Wider Systemic Distribution Injectable BPC-157 bypasses the digestive system, allowing for greater systemic distribution in the body
Frequently asked questions Straight answers on blend ratios, anchor compounds, and reconstitution volumes for multi-peptide research protocols